Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339) [Phase 3]
Phase 3 trial evaluating the efficacy of pantoprazole for gastroesophageal reflux symptoms in adults 18 and older; study completed.
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708) [Phase 3]
Phase 3 long-term trial of pantoprazole in patients with chronic acid-related symptoms (GERD and peptic ulcers) has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004) [Phase 3]
This Phase 3 trial update reports on the efficacy of pantoprazole in adults with non-erosive reflux disease or gastroesophageal reflux disea…
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506) [Phase 4]
Phase 4 clinical trial update evaluating a questionnaire after pantoprazole treatment at full and half doses in adults with gastroesophageal…
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340) [Phase 4]
A Phase 4 trial evaluated the minimal clinically important difference in symptom relief after pantoprazole treatment in patients with gastro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511) [Phase 4]
A Phase 4 clinical trial evaluating treatment-induced changes in GERD-related symptoms (BY1023/NL511) conducted by Takeda has been terminate…
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342) [Phase 4]
Phase 4 clinical trial updating a comparison of healing concepts after pantoprazole treatment in adults with erosive gastroesophageal reflux…
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients
A completed AstraZeneca-sponsored clinical trial update describing symptom control and impact on daily life in patients with gastroesophagea…
-
CLINICAL_TRIALS trial_result · 2012-04-13Clinical Trial Update: Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis [Phase 2, Phase 3]
A double-blind study comparing E3810 tablets (10 mg or 20 mg twice daily) to evaluate efficacy and safety in patients with refractory reflux…
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux Disease [Phase 1]
Phase 1 study evaluating the pharmacokinetics and safety of dexlansoprazole in pediatric subjects with symptomatic gastroesophageal reflux d…
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: Intraoperative Use of Dexketoprofen Trometamol, Pethidine Hcl, Tramadol Hcl and Their Combinations for Postoperative Pain Management in Laparoscopic Nissen Fundoplication [Phase 4]
Phase 4 clinical trial evaluating intraoperative analgesic regimens—dexketoprofen trometamol, pethidine hydrochloride, tramadol hydrochlorid…
-
CLINICAL_TRIALS trial_result · 2012-03-22Clinical Trial Update: Detection of Minimal Change Esophagitis by I-scan
A completed clinical trial evaluating detection of minimal change esophagitis using I-scan in patients with gastroesophageal reflux disease …
-
CLINICAL_TRIALS trial_result · 2012-03-14Clinical Trial Update: Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Subjects [Phase 1]
Phase 1 pharmacodynamic and pharmacokinetic study of E3710 in healthy Japanese male volunteers has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-24Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Single Rising Doses of YF476, a Gastrin Antagonist, in Healthy Men [Phase 1]
Phase 1 study assessing safety, tolerability, and pharmacokinetics of single rising doses of YF476, a gastrin antagonist, in healthy male vo…
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance [NA]
A completed clinical trial evaluating the impact of GERD/nighttime heartburn on driving performance, sponsored by David A. Johnson, MD.
-
CLINICAL_TRIALS trial_result · 2012-02-02Clinical Trial Update: A Study of Disposable Transnasal Esophagoscope
A completed clinical trial studying a disposable transnasal esophagoscope, sponsored by Yonsei University, evaluating conditions including g…
-
CLINICAL_TRIALS trial_result · 2012-01-18Clinical Trial Update: Comparison of Laparoscopic Hill and Laparoscopic Nissen Anti-Reflux Procedures [NA]
A clinical trial comparing two laparoscopic anti-reflux procedures for gastroesophageal reflux disease has completed. Sponsored by Swedish M…
-
CLINICAL_TRIALS trial_result · 2012-01-12Clinical Trial Update: Efficacy Study of Ilaprazole to Treat Erosive Esophgitis [Phase 3]
Phase 3 efficacy study of ilaprazole for erosive esophagitis and GERD has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-09Clinical Trial Update: Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux Disease [NA]
A completed clinical trial assessed the effect of a very low carbohydrate diet on gastroesophageal reflux disease in overweight individuals.
-
CLINICAL_TRIALS trial_result · 2011-12-29Clinical Trial Update: Esophageal Calibration During Laparoscopic Fundoplication Reduces Dysphagia [NA]
The completed trial indicates that calibrating the esophagus during laparoscopic fundoplication reduces postoperative dysphagia. This surgic…
-
CLINICAL_TRIALS trial_result · 2011-12-28Clinical Trial Update: Study Evaluating Pantoprazole in Children With GERD [Phase 3]
A Phase 3 pediatric trial evaluating pantoprazole for gastroesophageal reflux disease in children has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2011-12-15Clinical Trial Update: Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy [NA]
Completed trial update evaluating which supraesophageal reflux symptoms reliably respond to proton-pump inhibitor therapy in gastroesophagea…
-
CLINICAL_TRIALS trial_result · 2011-11-21Clinical Trial Update: Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease [Phase 2, Phase 3]
Phase 2/Phase 3 trial of famotidine in non-erosive gastroesophageal reflux disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-21Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD) [Phase 2]
A Phase 2 study evaluating the safety, tolerability and pharmacodynamics of pumosetrag in patients with gastroesophageal reflux disease, whi…
-
CLINICAL_TRIALS trial_result · 2011-09-21Clinical Trial Update: Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease [Phase 3]
A Phase 3 efficacy trial evaluating AGSPT201 tablets for gastroesophageal reflux disease has completed.